Related Experiment Video
Updated: Aug 14, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
Ensemble feature selection with data-driven thresholding for Alzheimer's disease biomarker discovery
Annette Spooner1, Gelareh Mohammadi2, Perminder S Sachdev3
1School of Computer Science and Engineering, University of New South Wales, Sydney, Australia. a.spooner@unsw.edu.au.
BMC Bioinformatics
|January 9, 2023
Summary
Ensemble feature selection with data-driven thresholds improves stability and reproducibility in identifying biomarkers for Alzheimer's disease (AD), outperforming individual methods without sacrificing performance.
Area of Science:
- Computational Biology
- Bioinformatics
- Neuroscience
Background:
- High-dimensional data often leads to unstable feature selection results.
- Ensemble methods enhance feature selection stability by aggregating multiple base selectors.
- Fixed thresholds in ensemble methods may not guarantee relevant feature identification.
Purpose of the Study:
- To evaluate data-driven thresholds for automatic relevant feature identification in ensemble feature selection.
- To assess the predictive accuracy and stability of ensemble feature selection with data-driven thresholds.
- To apply these methods to Alzheimer's disease (AD) datasets for biomarker discovery.
Main Methods:
- Ensemble feature selection incorporating data-driven thresholds.
- Evaluation of robust rank aggregation and information retrieval threshold algorithms.
- Application to two real-world Alzheimer's disease datasets.
Main Results:
- Ensemble methods with data-driven thresholds improved stability by up to 34% compared to individual selectors.
- Robust rank aggregation and threshold algorithm proved most effective.
- Identified features align with current Alzheimer's disease literature.
Conclusions:
- Data-driven thresholds enhance feature selection stability and reproducibility in ensemble methods.
- Eliminates the need for arbitrary fixed thresholds, leading to more meaningful feature sets.
- Enables the development of interpretable models by highlighting key disease factors.
Related Concept Videos
Alzheimer's Disease: Overview
600
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
600
Alzheimer's Disease: Treatment
238
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
238

